SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-19-002356
Filing Date
2019-05-21
Accepted
2019-05-21 13:00:32
Documents
13
Period of Report
2019-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5454
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 4498
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 714110
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 645
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 669
6 GRAPHIC cslogo.jpg GRAPHIC 1668
7 GRAPHIC exhibit99-2x30x1.jpg GRAPHIC 11596
8 GRAPHIC exhibit99-2x40x1.jpg GRAPHIC 30487
9 GRAPHIC exhibit99-3x1x1.jpg GRAPHIC 106002
10 GRAPHIC exhibit99-3x2x1.jpg GRAPHIC 54595
11 GRAPHIC exhibit99-4x1x1.jpg GRAPHIC 98425
12 GRAPHIC exhibit99-4x2x1.jpg GRAPHIC 105849
13 GRAPHIC trilogo.jpg GRAPHIC 6353
  Complete submission text file 0001062993-19-002356.txt   1298889
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 19841709
SIC: 2834 Pharmaceutical Preparations